Pre-emptive treatment of heart failure exacerbations in patients managed with the HeartLogic™ algorithm.

ABSTRACT:

Aims

Heart failure (HF) is a chronic disease affecting 64 million people worldwide and places a severe burden on society because of its mortality, numerous re-hospitalizations and associated costs. HeartLogic™ is an algorithm programmed into implanted devices incorporating several biometric parameters which aims to predict HF episodes. It provides an index which can be monitored remotely, allowing pre-emptive treatment of congestion to prevent acute decompensation. We aim to assess the impact and security of pre-emptive HF management, guided by the HeartLogic™ index.

Methods and results

The HeartLogic™ France Cohort Study is an investigator-initiated, prospective, multi-centre, non-randomized study. Three hundred ten patients with a history of HF (left ventricular ejection f

SUBMITTER: Garcia R 

PROVIDER: S-EPMC10966255 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature